Carol Aghajanian Selected Research

Granulosa Cell Tumor

1/2020	Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.
3/2015	The role of systemic chemotherapy in the management of granulosa cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carol Aghajanian Research Topics

Disease

86	Neoplasms (Cancer) 10/2022 - 08/2002
78	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 02/2002
35	Carcinoma (Carcinomatosis) 04/2022 - 02/2002
21	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 10/2004
21	Ovarian Epithelial Carcinoma 01/2021 - 02/2002
19	Disease Progression 01/2021 - 04/2004
7	Neutropenia 01/2022 - 08/2007
7	Leiomyosarcoma 01/2017 - 06/2002
6	Hypertension (High Blood Pressure) 07/2022 - 01/2010
6	Fatigue 01/2022 - 12/2007
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2007
6	Anemia 01/2022 - 01/2017
6	Nausea 10/2021 - 02/2016
5	Fallopian Tube Neoplasms 12/2021 - 06/2012
5	Hypersensitivity (Allergy) 05/2019 - 03/2002
4	Carcinosarcoma 01/2017 - 09/2012
3	Asthenia 10/2021 - 02/2016
3	Diarrhea 01/2019 - 09/2006
3	Abdominal Pain (Pain, Abdominal) 01/2019 - 05/2004
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 01/2019
2	Residual Neoplasm 01/2022 - 02/2008
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 07/2005
2	Thrombocytopenia (Thrombopenia) 10/2021 - 12/2019
2	Leukopenia 01/2021 - 01/2010
2	Granulosa Cell Tumor 01/2020 - 03/2015
2	Microsatellite Instability 01/2019 - 12/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 10/2002
2	Hemorrhage 01/2017 - 07/2015
2	Hyponatremia 01/2017 - 08/2007
2	Brain Neoplasms (Brain Tumor) 02/2013 - 10/2002
2	Testicular Neoplasms (Testicular Cancer) 12/2012 - 05/2008
2	Lymphoma (Lymphomas) 12/2012 - 03/2007
1	Chromosomal Instability (Chromosome Stability) 01/2022

Drug/Important Bio-Agent (IBA)

39	PlatinumIBA 01/2022 - 03/2002
22	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2002
22	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 03/2002
21	Bevacizumab (Avastin)FDA Link 10/2022 - 08/2006
12	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 06/2015
10	rucaparibIBA 12/2021 - 10/2017
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2004
8	olaparibIBA 01/2022 - 02/2016
8	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2015
7	veliparibIBA 01/2022 - 06/2015
7	Gemcitabine FDA Link 04/2014 - 06/2002
6	Pharmaceutical PreparationsIBA 01/2021 - 12/2004
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021 - 02/2016
5	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
5	EnzymesIBA 01/2017 - 08/2004
4	temsirolimus FDA Link 10/2022 - 04/2013
4	AntigensIBA 07/2022 - 05/2008
4	pembrolizumabIBA 08/2021 - 01/2019
4	ixabepilone (BMS 247550)FDA Link 01/2018 - 03/2007
4	ImmunosorbentsIBA 06/2011 - 08/2004
3	VaccinesIBA 07/2022 - 12/2012
3	MK 2206IBA 04/2022 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2018
3	Peptides (Polypeptides)IBA 01/2021 - 05/2008
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2019
3	taxaneIBA 02/2016 - 08/2007
3	Bortezomib (Velcade)FDA Link 11/2009 - 08/2002
2	Combined VaccinesIBA 07/2022 - 12/2019
2	Biological ProductsIBA 01/2022 - 01/2022
2	peposertibIBA 01/2022 - 12/2019
2	Poly Adenosine Diphosphate RiboseIBA 12/2021 - 01/2021
2	atezolizumabIBA 10/2021 - 10/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 12/2019
2	TubulinIBA 10/2020 - 01/2017
2	fosbretabulin (combretastatin A4)IBA 10/2020 - 01/2016
2	lenvatinibIBA 10/2020 - 01/2019
2	IpilimumabIBA 01/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 12/2019 - 12/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 06/2002
2	GSK2141795IBA 12/2019 - 12/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 06/2011
2	human ALK1-Fc fusion proteinIBA 01/2018 - 07/2015
2	iniparibIBA 02/2016 - 09/2012
2	Glutamic Acid (Glutamate)FDA Link 02/2013 - 11/2004
2	Epothilones (Epothilone)IBA 12/2012 - 03/2007
2	Estrogens (Estrogen)FDA Link 03/2012 - 09/2004
2	Monoclonal AntibodiesIBA 06/2011 - 09/2006
2	Proteasome InhibitorsIBA 12/2004 - 08/2002
1	Hormones (Hormone)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 10/2022 - 02/2002
50	Therapeutics 04/2022 - 02/2002
4	Retreatment 05/2019 - 03/2002
4	Radiotherapy 11/2018 - 10/2002
3	Cytoreduction Surgical Procedures 10/2021 - 05/2006
3	Immunotherapy 01/2020 - 10/2019
3	Adjuvant Chemotherapy 03/2015 - 12/2004
3	Lymph Node Excision (Lymph Node Dissection) 10/2013 - 11/2006
2	Hyperthermic Intraperitoneal Chemotherapy 01/2022 - 10/2021
2	Salpingo-oophorectomy 01/2022 - 01/2021
2	Hysterectomy 01/2022 - 11/2006
2	Neoadjuvant Therapy 01/2020 - 03/2016
2	Aftercare (After-Treatment) 01/2018 - 12/2003
2	Premedication 03/2010 - 11/2004